Alba Dalmases

1.7k total citations · 1 hit paper
23 papers, 1.0k citations indexed

About

Alba Dalmases is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Alba Dalmases has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Alba Dalmases's work include Lung Cancer Treatments and Mutations (10 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Genomics and Diagnostics (5 papers). Alba Dalmases is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Genomics and Diagnostics (5 papers). Alba Dalmases collaborates with scholars based in Spain, Germany and United Kingdom. Alba Dalmases's co-authors include Joan Albanell, Ana Rovira, Beatríz Bellosillo, Mar Iglesias, Federico Rojo, Marta Salido, Sergi Serrano, Clara Montagut, Joaquim Bellmunt and Manuel Gallén and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Alba Dalmases

23 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer

2012 367 citations Clara Montagut, Alba Dalmases et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alba Dalmases Spain	12	673	484	366	355	275	23	1.0k
Sandra Misale United States	9	730 1.1×	437 0.9×	283 0.8×	361 1.0×	242 0.9×	24	1.1k
Emanuele Valtorta Italy	16	661 1.0×	357 0.7×	331 0.9×	531 1.5×	258 0.9×	40	1.2k
Yihuan Xu United States	11	559 0.8×	360 0.7×	236 0.6×	331 0.9×	249 0.9×	20	1.1k
Maria Pia Morelli United States	19	863 1.3×	350 0.7×	355 1.0×	449 1.3×	272 1.0×	70	1.3k
Claudia Cardone Italy	15	700 1.0×	274 0.6×	288 0.8×	330 0.9×	251 0.9×	42	1.0k
Karen Velastegui United States	14	807 1.2×	276 0.6×	411 1.1×	532 1.5×	197 0.7×	22	1.2k
Luca Lazzari Italy	14	433 0.6×	261 0.5×	190 0.5×	446 1.3×	162 0.6×	25	853
Marisol Huerta Spain	18	610 0.9×	491 1.0×	398 1.1×	368 1.0×	253 0.9×	42	1.2k
S. Gail Eckhardt United States	14	779 1.2×	302 0.6×	470 1.3×	686 1.9×	179 0.7×	46	1.3k
Alessandra Balduzzi Italy	18	710 1.1×	626 1.3×	169 0.5×	247 0.7×	172 0.6×	35	1.0k

Countries citing papers authored by Alba Dalmases

Since Specialization

Citations

This map shows the geographic impact of Alba Dalmases's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alba Dalmases with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alba Dalmases more than expected).

Fields of papers citing papers by Alba Dalmases

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alba Dalmases. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alba Dalmases. The network helps show where Alba Dalmases may publish in the future.

Co-authorship network of co-authors of Alba Dalmases

This figure shows the co-authorship network connecting the top 25 collaborators of Alba Dalmases. A scholar is included among the top collaborators of Alba Dalmases based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alba Dalmases. Alba Dalmases is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Navarro, Gemma, Alba Dalmases, Agustín Seoane, et al.. (2021). Predictors of Metachronous Risk Polyps After Index Colonoscopy. Clinical and Translational Gastroenterology. 12(2). e00304–e00304. 5 indexed citations

Sánchez-Martín, Francisco Javier, Oriol Arpí, Laura Visa, et al.. (2019). HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer. Molecular Cancer Therapeutics. 18(11). 2135–2145. 42 indexed citations

Clavé, Sergi, Álvaro Taus, Pedro Rocha, et al.. (2019). Concomitant genomic alterations in KRAS mutant advanced lung adenocarcinoma. Lung Cancer. 140. 42–45. 14 indexed citations

Pijuán, Lara, Sergi Mojal, Marta Salido, et al.. (2019). Complementary value of electron microscopy and immunohistochemistry in the diagnosis of non-small cell lung cancer: A potential role for electron microscopy in the era of targeted therapy. Ultrastructural Pathology. 43(6). 237–247. 1 indexed citations

Taus, Álvaro, Pedro Rocha, Lara Pijuán, et al.. (2018). Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung Adenocarcinoma. Clinical Lung Cancer. 19(5). 387–394.e2. 44 indexed citations

Sánchez‐Font, Albert, Roberto Chalela, Clara Martín‐Ontiyuelo, et al.. (2018). Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy‐guided bronchoscopy. Cancer Cytopathology. 126(10). 860–871. 11 indexed citations

Clavé, Sergi, Alba Dalmases, Raquel Longarón, et al.. (2017). P1.02-048 MET Exon 14 Skipping Mutations and Gene Amplifications Are Not Simultaneous Events in NSCLC. Journal of Thoracic Oncology. 12(1). S516–S517. 1 indexed citations

Vidal, Joana, Alba Dalmases, Frederick S. Jones, et al.. (2017). Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients. Annals of Oncology. 28(6). 1325–1332. 255 indexed citations

Taus, Álvaro, Ainhoa Hernández, Eva López, et al.. (2017). P1.02-039 Assessment of KRAS mutations (by Digital PCR) in Circulating Tumoral DNA from Lung Adenocarcinoma Patients. Journal of Thoracic Oncology. 12(1). S511–S511. 1 indexed citations

10.

Dalmases, Alba, Alicia Abalo, Mar Iglesias, et al.. (2016). Accuracy of plasma RAS mutation testing for therapy selection and monitoring of colorectal cancer patients. Annals of Oncology. 27. vi176–vi176. 1 indexed citations

11.

Clavé, Sergi, Alba Dalmases, Raquel Longarón, et al.. (2016). 11P Prognostic impact of MET mutations in exon 14 and copy number alterations in a series of NSCLC patients. Journal of Thoracic Oncology. 11(4). S61–S61. 1 indexed citations

12.

Casadevall, David, Joana Vidal, Fernando Gallardo, et al.. (2016). Dabrafenib in an elderly patient with metastatic melanoma and BRAF V600R mutation: a case report. Journal of Medical Case Reports. 10(1). 158–158. 8 indexed citations

13.

García-Parra, Jetzabel, Alba Dalmases, Beatriz Morancho, et al.. (2014). Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer. European Journal of Cancer. 50(15). 2725–2734. 22 indexed citations

14.

Montagut, Clara, Beatríz Bellosillo, Iria González, et al.. (2014). Evolution of heterogeneous mechanisms of acquired resistance to cetuximab-based therapy in colorectal cancer.. Journal of Clinical Oncology. 32(15_suppl). 3526–3526. 5 indexed citations

15.

Inglés‐Esteve, Julia, M.L González Morales, Alba Dalmases, et al.. (2012). Inhibition of Specific NF-κB Activity Contributes to the Tumor Suppressor Function of 14-3-3σ in Breast Cancer. PLoS ONE. 7(5). e38347–e38347. 25 indexed citations

16.

Montagut, Clara, Alba Dalmases, Beatríz Bellosillo, et al.. (2012). Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer. Nature Medicine. 18(2). 221–223. 367 indexed citations breakdown →

17.

Montagut, Clara, Mar Iglesias, Beatríz Bellosillo, et al.. (2010). Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients. British Journal of Cancer. 102(7). 1137–1144. 21 indexed citations

18.

Albanell, Joan, Alba Dalmases, Ana Rovira, & Federico Rojo. (2007). mTOR signaling in human cancer. Clinical & Translational Oncology. 9(8). 484–493. 50 indexed citations

19.

Dalmases, Alba, Marta Bosch, Vanessa Rodríguez‐Fanjul, et al.. (2007). Inhibition of the Canonical IKK/NFκB Pathway Sensitizes Human Cancer Cells to Doxorubicin. Cell Cycle. 6(18). 2284–2292. 58 indexed citations

20.

Rojo, Federico, Alba Dalmases, Josep Corominas, & Joan Albanell. (2007). Pharmacodynamics: biological activity of targeted therapies in clinical trials. Clinical & Translational Oncology. 9(10). 634–644. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact